Two Sigma Investments, LP Akebia Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 24,848 shares of AKBA stock, worth $53,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,848

Holding current value

$53,920

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.94 - $1.55 $23,357 - $38,514	24,848 New	24,848 $32,000
Q4 2023 Feb 14, 2024	BUY	$0.8 - $1.28 $126,350 - $202,160	157,938 Added 575.14%	185,399 $229,000
Q3 2023 Nov 14, 2023	SELL	$0.87 - $1.84 $164,214 - $347,303	-188,752 Reduced 87.3%	27,461 $31,000
Q2 2023 Aug 14, 2023	BUY	$0.51 - $1.43 $110,268 - $309,184	216,213 New	216,213 $198,000
Q4 2022 Feb 14, 2023	SELL	$0.25 - $0.58 $40,768 - $94,581	-163,072 Reduced 30.35%	374,289 $217,000
Q3 2022 Nov 14, 2022	BUY	$0.3 - $0.46 $97,143 - $148,953	323,812 Added 151.63%	537,361 $170,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.67 $68,335 - $143,077	213,549 New	213,549 $75,000
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $69,965 - $284,719	-97,174 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $219,613 - $324,561	97,174 New	97,174 $220,000
Q2 2021 Aug 16, 2021	SELL	$2.83 - $4.2 $1.77 Million - $2.63 Million	-626,577 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.92 - $5.06 $308,743 - $535,014	105,734 Added 20.3%	626,577 $2.12 Million
Q4 2020 Feb 16, 2021	BUY	$2.22 - $3.78 $1.16 Million - $1.97 Million	520,843 New	520,843 $1.46 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $13.08 $930,768 - $5.09 Million	-389,443 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $2.47 Million - $5.02 Million	369,616 Added 1864.21%	389,443 $5.29 Million
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $7,285 - $18,196	1,777 Added 9.84%	19,827 $150,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $57,038 - $121,476	18,050 New	18,050 $114,000
Q2 2019 Aug 14, 2019	SELL	$4.1 - $8.05 $342,538 - $672,545	-83,546 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $288,401 - $465,387	-53,309 Reduced 38.95%	83,546 $684,000
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $526,705 - $894,128	97,719 Added 249.69%	136,855 $757,000
Q3 2018 Nov 14, 2018	BUY	$7.44 - $10.65 $291,171 - $416,798	39,136 New	39,136 $346,000
Q2 2018 Aug 14, 2018	SELL	$9.15 - $11.34 $210,440 - $260,808	-22,999 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.53 - $15.68 $219,180 - $360,624	22,999 New	22,999 $219,000
Q4 2017 Feb 14, 2018	SELL	$14.24 - $19.59 $2.2 Million - $3.02 Million	-154,293 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.06 - $19.67 $2.02 Million - $3.03 Million	154,293	154,293 $3.04 Million

Others Institutions Holding AKBA

# of Institutions

124

Shares Held

55M

Call Options Held

291K

Put Options Held

179K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $399M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Akebia Therapeutics, Inc. Transaction History